[Effect of 1-desamino-8-D-arginine-vasopressin in limited renal function].
U-Deamino-8-D-arginine-vasopressin (DDAVP) is a new synthetic antidiuretic hormone with prolonged action. 0.02 mg given intranasally to 38 patients with far advanced chronic renal failure effected an instantaneous decrease in urine volume as well as an augmentation of U/P-inulin ratio, fraction of filtered sodium and chloride excreted and of the absolute elimination of these ions. These findings suggest an improvement of permeability at the descending limb of Henle, too, the latter and a diminution of circulation in the renal medulla being responsible for the increase in renal salt loss after DDAVP. A rise of blood pressure or other side effects could not be observed.
D000281:Administration, Intranasal; D001120:Arginine / Q000494:pharmacology; D002712:Chlorides / Q000097:blood / Q000652:urine; D004231:Diuresis / Q000187:drug effects; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000503:physiopathology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D007677:Kidney Function Tests; D008297:Male; D011704:Pyelonephritis / Q000503:physiopathology; D012964:Sodium / Q000097:blood / Q000652:urine; D014667:Vasopressins / Q000032:analysis* / Q000494:pharmacology
D002712:Chlorides; D014667:Vasopressins; D001120:Arginine; D012964:Sodium
Die Wirkung von 1-Desamino-8-D-arginin-vasopressin-diacetat bei eingeschränkter Nierenfunktion